Literature DB >> 19052138

Osteosarcoma derived from donor stem cells carrying the Norrie's disease gene.

Massimo Berger, Michela Muraro, Franca Fagioli, Stefano Ferrari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19052138     DOI： 10.1056/NEJMc0807172

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.

Authors:  Zhihao Guo; Tianji Zhang; Juntao Wu; Hongwei Wang; Xiaotan Liu; Linqiang Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

Review 3.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

4.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

5.  Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.

Authors:  Zhang Tie; Rui Bai; Zhongwen Zhai; Gang Zhang; Hong Zhang; Zhenqun Zhao; Deshan Zhou; Wanlin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

6.  Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics.

Authors:  Luis Del Valle; Sergio Piña-Oviedo; Georgina Perez-Liz; Brian J Augelli; S Ausim Azizi; Kamel Khalili; Jennifer Gordon; Barbara Krynska
Journal:  Cancer Biol Ther       Date:  2010-02-01       Impact factor: 4.742

7.  Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.

Authors:  Bekim Sadikovic; Paul Thorner; Susan Chilton-Macneill; Jeff W Martin; Nilva K Cervigne; Jeremy Squire; Maria Zielenska
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

8.  Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.

Authors:  Yu He; XinJun Liang; ChunQing Meng; ZengWu Shao; Yong Gao; Qiang Wu; JianXiang Liu; Hong Wang; ShuHua Yang
Journal:  Int Orthop       Date:  2014-05-31       Impact factor: 3.075

9.  Asymmetric aneuploidy in mesenchymal stromal cells detected by in situ karyotyping and fluorescence in situ hybridization: suggestions for reference values for stem cells.

Authors:  Seon Young Kim; Kyongok Im; Si Nae Park; Jiseok Kwon; Jung-Ah Kim; Qute Choi; Sang Mee Hwang; Sung-Hee Han; Sunghoon Kwon; Il-Hoan Oh; Dong Soon Lee
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

10.  Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture.

Authors:  Anne-Marie Cleton-Jansen; Arjan C Lankester; Emilie P Buddingh; S Eriaty N Ruslan; Christianne M A Reijnders; Karoly Szuhai; Marieke L Kuijjer; Helene Roelofs; Pancras C W Hogendoorn; R Maarten Egeler
Journal:  Clin Sarcoma Res       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.